glucagon-like peptide-1 (GLP-1) receptor agonistsScientists
… weight loss and the incidence of side effects in people taking glucagon-like peptide-1 (GLP-1) receptor agonists.…
7articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Glucagon-like peptide-1 (GLP-1) receptor agonists
This drug is selected. Its supporting articles are shown below.
Articles mentioning Glucagon-like peptide-1 (GLP-1) receptor agonists
7 articles · page 1 of 1glucagon-like peptide-1 (GLP-1) receptor agonistsobesitystructured behavioural interventionspharmacotherapy
…We agree with Sun’s central assertion: glucagon-like peptide-1 (GLP-1) receptor agonists are not “magic bullets” for the treatment of obesity.12 West an…
glucagon-like peptide-1 (GLP-1) receptor agonistspharmacological weight loss treatment
…an average weight regain of 0.4 kg per month after cessation of glucagon-like peptide-1 (GLP-1) receptor agonists, indicates that weight may return to baseline within approximat…
glucagon-like peptide-1 (GLP-1) receptor agonistsUK regulators
…and patients around a rare but potentially fatal side effect of glucagon-like peptide-1 (GLP-1) receptor agonists has been issued by UK regulators.…
acetazolamidetopiramateglucagon-like peptide-1 (GLP-1) receptor agonistsIdiopathic intracranial hypertension (IIH)Weight losslifestyle modificationssurgical interventionspharmacologic agentsbariatric surgery
…weight, limiting applicability. Pharmacologic therapies such as acetazolamide, topiramate, and glucagon-like peptide-1 (GLP-1) receptor agoni…
fibroblast growth factor-21 analoguesdiacylglycerol O-acyltransferase 2 inhibitorsthyroid hormone receptor-beta (THR-β) agonistsperoxisome proliferator-activated receptor agonistsglucagon-like peptide-1 (GLP-1) receptor agonistsTHR-β agonistsacetyl-CoA carboxylase (ACC) inhibitorsMetabolic dysfunction-associated steatohepatitisMASHmultitargeted combination therapies
… such as glucagon-like peptide-1 (GLP-1) receptor agonists with fibroblast growth factor-21 analogues or THR-β agonists, aim to optimise metabolic outcomes, includin…
Glucagon-like peptide-1 (GLP-1) receptor agonistsGLP-1 agonistGLP-1 agonistsobstructive lung diseaseCOPDtype 2 diabetes mellituschronic obstructive pulmonary diseasebacterial pneumoniacardiovascular and renal diseasenon-invasive ventilation+1 more
…Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists are novel antihyperglycemic agents that have demonstrated benef…